We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SITO
1176
DELISTED
SITO MOBILE, LTD
SITO
$62K 0.01%
+9,288
New +$65.4K
XIV
1177
DELISTED
VelocityShares Daily Inverse VIX Short Term ETN
XIV
$62K 0.01%
462
-59,216
-99% -$6.85M
BAH icon
1178
Booz Allen Hamilton
BAH
$9.15B
$61K 0.01%
1,595
+1,356
+567% +$51.3K
CCRN
1179
DELISTED
Cross Country Healthcare
CCRN
$61K 0.01%
4,774
+1,186
+33% +$15.7K
FLXS icon
1180
Flexsteel Industries
FLXS
$311M
$61K 0.01%
1,298
-1,845
-59% -$90.3K
FMAO icon
1181
Farmers & Merchants Bancorp
FMAO
$481M
$61K 0.01%
1,506
+841
+126% +$33.1K
JNPR
1182
DELISTED
Juniper Networks
JNPR
$61K 0.01%
2,145
+1,564
+269% +$42.2K
KTCC icon
1183
Key Tronic
KTCC
$44.7M
$61K 0.01%
8,818
+8,110
+1,145% +$58.4K
MAG
1184
DELISTED
MAG Silver
MAG
$61K 0.01%
3,958
-2,401
-38% -$27.1K
OMCL icon
1185
Omnicell
OMCL
$1.68B
$61K 0.01%
1,261
+96
+8% +$4.84K
ICPT
1186
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$61K 0.01%
1,036
+258
+33% +$16.3K
CHUBK
1187
DELISTED
CommerceHub, Inc. Series C Common Stock
CHUBK
$61K 0.01%
2,951
-1,121
-28% -$23.7K
CCL icon
1188
Carnival Corporation Ltd
CCL
$39.7B
$60K 0.01%
902
+802
+802% +$53.1K
CWEN icon
1189
Clearway Energy Class C
CWEN
$6.7B
$60K 0.01%
3,185
+1,369
+75% +$26K
EXPE icon
1190
Expedia Group
EXPE
$37.3B
$60K 0.01%
499
-4,910
-91% -$637K
NVMI
1191
Nova
NVMI
$12.5B
$60K 0.01%
+2,325
New +$65.5K
PRK icon
1192
Park National Corp
PRK
$3.67B
$60K 0.01%
580
-1,157
-67% -$125K
MYOV
1193
DELISTED
Myovant Sciences Ltd.
MYOV
$60K 0.01%
4,741
-10,339
-69% -$139K
TLGT
1194
DELISTED
Teligent, Inc
TLGT
$60K 0.01%
1,654
+506
+44% +$24.2K
CLCT
1195
DELISTED
Collectors Universe
CLCT
$60K 0.01%
2,096
+1,719
+456% +$46.1K
ARRY
1196
DELISTED
Array Biopharma Inc
ARRY
$60K 0.01%
4,658
-23,860
-84% -$271K
AHL
1197
DELISTED
ASPEN Insurance Holding Limited
AHL
$60K 0.01%
1,462
-1,419
-49% -$58.7K
LNCE
1198
DELISTED
Snyders-Lance, Inc.
LNCE
$60K 0.01%
1,203
-9,570
-89% -$380K
AFG icon
1199
American Financial Group
AFG
$12.1B
$59K 0.01%
+541
New +$56.8K
ATEX icon
1200
Anterix
ATEX
$1.94B
$59K 0.01%
1,825
+1,669
+1,070% +$53.7K

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.